Structure Therapeutics Inc.
GPCR
$54.51
-$0.19-0.35%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -20.05% | -18.85% | -15.24% | -90.58% | -78.17% |
| Total Depreciation and Amortization | 104.97% | 89.89% | 68.47% | 47.74% | 76.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 258.61% | 320.04% | 178.03% | 517.53% | 205.67% |
| Change in Net Operating Assets | -388.39% | -92.01% | -3,070.34% | -15.45% | 299.73% |
| Cash from Operations | -35.19% | -14.80% | -90.51% | -90.63% | -58.57% |
| Capital Expenditure | -237.45% | -210.82% | -180.16% | 12.18% | 51.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -489.00% | -37.59% | 123.25% | 111.20% | 79.61% |
| Cash from Investing | -470.62% | -35.21% | 125.02% | 111.68% | 79.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 30,638.81% | 47.90% | 47.98% | -92.71% | -99.69% |
| Repurchase of Common Stock | -1,846.15% | -1,846.15% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -78.25% | -18.01% | -12.47% | 96.20% | 93.97% |
| Cash from Financing | 64,218.67% | 47.46% | 47.99% | -92.70% | -99.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 153.54% | 202.16% | 1,486.47% | -156.97% | -168.79% |